Saul Marquez

In medtech, marketing has never been harder. Buying cycles are long, clinical decisions are multi-stakeholder, and product portfolios compete for attention inside the same accounts. So how do the best medtech marketing leaders actually build commercial momentum across a portfolio, not just for a single launch? Join Caitlin Mayer, Senior Director, US Marketing at Medtronic Acute Care & Monitoring, and Saul Marquez, CEO of Outcomes Rocket, for a candid conversation about what it takes to move from activity to impact. They will unpack the shift from feature-led to outcomes-led positioning, the role of voice-of-customer research in sharpening how a portfolio shows up in the market, and how aligning clinical, commercial, and marketing teams around a shared narrative accelerates pipeline velocity. Drawing on Outcomes Rocket's 2026 State of B2B GTM Strategy research and real work inside one of the most complex medtech portfolios, the session will explore how the right frameworks and partnerships help marketing leaders do more with the same team, prove contribution, and sustain momentum beyond the next budget cycle. Attendees will leave with a practical lens for prioritizing across a portfolio, a model for building a defensible commercial story, and a clearer view of when internal ownership is enough and when external partnership can help change the trajectory.